Covidien Reports No Procedure Slowdown, Boosts Fiscal 2008 Guidance
This article was originally published in The Gray Sheet
Executive Summary
Covidien's second quarter results, which beat analyst expectations, revealed no sign of a slowdown in U.S. surgical procedure volume, a trend that had been hinted at last month by Johnson & Johnson